Apple and Johnson & Johnson today announced that they will be working together on a new study to gather more information about atrial fibrillation and reduce the risk of stroke. This study will explore the potential enhancement of surveillance features for the iPhone and Apple Watch.
The study will be specifically designed for people over the age of 65. Apple and Johnson & Johnson are investigating whether Apple's health monitoring technology can help reduce the risk of stroke through early detection of atrial fibrillation, which is a leading cause of stroke in the United States and which is detectable thanks to the ECG function of the Apple Watch.
The problem is that atrial fibrillation is difficult to diagnose due to the lack of physical symptoms in most patients. With Apple Watch and ECG, it would be possible to warn users of the potential risks associated with atrial fibrillation, even when the user has no symptoms.
Those interested in participating in this study must be at least 65 years of age, reside in the United States, and have medical insurance. In addition, you must agree to give access to the data and have an iPhone 6s or later.
Once the participants have been randomly selected, they will be divided into two groups. One will only use the iPhone app, while the other will use the iPhone app in combination with an Apple Watch. The study will last three years.